Background The scale-up of HIV treatment programs has resulted in a reduction in HIV-
related morbidity and mortality. However, retention of patients in these programs remains a …

Objectives: To assess outcomes over the first 7 years of antiretroviral therapy (ART) at
Themba Lethu Clinic, Johannesburg, South Africa. Design: Observational cohort study …

Background The Nigerian Antiretroviral therapy (ART) program started in 2004 and now
ranks among the largest in Africa. However, nationally representative data on outcomes …

Introduction Despite increased treatment availability, HIV-infected individuals continue to
start antiretroviral therapy (ART) late in disease progression, increasing early mortality risk …

Background Antiretroviral therapy (ART) improves morbidity and mortality in patients with
HIV, however high rates of loss to follow-up (LTF) and mortality have been documented in …

Objective: Little is known about the temporal impact of the rapid scale-up of large
antiretroviral therapy (ART) services on programme outcomes. We describe patient …

Objective To date, data regarding the determinants of mortality in HIV‐infected patients
starting antiretroviral therapy (ART) in Africa have been primarily derived from routine …

Background Scale up of antiretroviral therapy (ART) has led to substantial declines in HIV
related morbidity and mortality. However, attrition from ART care remains a major public …

Introduction: National programs are facing challenges of loss to follow-up of people living
with HIV/AIDS (PLWHA) on antiretroviral therapy (ART). We sought to identify risk factors …

Background Short-medium term studies from sub-Saharan Africa show that, despite high
early mortality, substantial loss to program, and high rates toxicity, patients on antiretroviral …